Dr. Stephen Edge, director of the Baptist Cancer Center, was recently elected to the American Society of Clinical Oncology board of directors.
Dr. Edge is one of four new board members elected by worldwide members of ASCO. ASCO’s board of directors comprises oncology leaders who are elected to positions reflecting various specialties within the oncology field.
Dr. Edge, a breast oncologic surgeon who came to Baptist in the summer of 2013 to head the Cancer Center, has been active in cancer care quality measurement and health services research and national policy development. His primary research focus has been in defining quality assessment tools for cancer care and systems to improve community-wide cancer care. He is the immediate past-chair of the Commission on Cancer of the American College of Surgeons, past-chair of the American Joint Committee on Cancer, and editor of the seventh edition of the American Joint Committee on Cancer Staging Manual. Dr. Edge also served on the executive committee of the board of directors of the National Comprehensive Cancer Network and as a co-chair of the technical expert panel on cancer quality measures for the Centers for Medicare and Medicaid Services.
Most recently, Dr. Edge was slated to serve as the principal investigator of a National Cancer Institute grant awarded to the Baptist Cancer Center, which was chosen as one of 12 centers nationwide to spearhead clinical research focused on disparities in cancer care among minorities and historically underserved groups.
Founded in 1964, ASCO is the world’s leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals.